<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effects of a paramagnetic contrast agent, <z:chebi fb="0" ids="33375">gadolinium</z:chebi>-<z:chebi fb="0" ids="35739">DTPA</z:chebi> (Gd-<z:chebi fb="0" ids="35739">DTPA</z:chebi>), on magnetic resonance (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>) imaging of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was investigated in a feline model of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Imaging was performed both before and after administration of an intravenous dose of 0.2 mmol/kg of Gd-<z:chebi fb="0" ids="35739">DTPA</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>The animals were then sacrificed for pathologic correlation </plain></SENT>
<SENT sid="3" pm="."><plain>No changes in intensity or relaxation times were noted before or after Gd-<z:chebi fb="0" ids="35739">DTPA</z:chebi> administration in two animals with 2 hours of occlusion </plain></SENT>
<SENT sid="4" pm="."><plain><z:mpath ids='MPATH_124'>Infarcts</z:mpath> were noted before and after contrast enhancement in <z:hpo ids='HP_0000001'>all</z:hpo> six cats with <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> of greater than 16-hours duration </plain></SENT>
<SENT sid="5" pm="."><plain>Gd-<z:chebi fb="0" ids="35739">DTPA</z:chebi> caused significant increase in intensity of <z:mpath ids='MPATH_124'>infarct</z:mpath> but not in that of <z:mpath ids='MPATH_458'>normal</z:mpath> cerebral tissue </plain></SENT>
<SENT sid="6" pm="."><plain>Rapid enhancement was visible in <z:mpath ids='MPATH_124'>infarcts</z:mpath> of 16-24 hours, but such enhancement was slower in <z:mpath ids='MPATH_124'>infarcts</z:mpath> of 72-168 hours, presumably owing to slowed inflow caused by increased vasogenic <z:hpo ids='HP_0000969'>edema</z:hpo> in the latter group </plain></SENT>
<SENT sid="7" pm="."><plain>Contrast enhancement of <z:hpo ids='HP_0011009'>acute</z:hpo> cerebral ischemic lesions with Gd-<z:chebi fb="0" ids="35739">DTPA</z:chebi> offers no improvement in sensitivity of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> imaging, although the conspicuity of the lesion may be improved </plain></SENT>
<SENT sid="8" pm="."><plain>Additionally, contrast media may provide potential temporal and pathophysiological data for better characterization of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>